Viewpoints
New molecules for treating Metabolic-associated dysfunction steatotic liver disease (MASLD)
Manuel Romero-Gómez
Corresponding author
mromerogomez@us.es
Address for correspondence: Prof. Dr. Manuel Romero-Gómez. UCM Digestive Diseases, Ground floor, Hospital General, Virgen del Rocio University Hospital, Avda Manuel Siurot s/n 41013 Sevilla, Spain.
Address for correspondence: Prof. Dr. Manuel Romero-Gómez. UCM Digestive Diseases, Ground floor, Hospital General, Virgen del Rocio University Hospital, Avda Manuel Siurot s/n 41013 Sevilla, Spain.
UCM Digestive Diseases, Virgen del Rocio University Hospital, SeLiver Group, Institute of Biomedicine of Seville, Ciberehd, Department of Medicine, University of Seville, Seville, Spain
